Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
Completed · Phase 1
Conditions studied: Pulmonary Hypertension, COPD
In brief
An Open Label, Pilot Study Testing the Safety and Efficacy of Inhaled Treprostinil (Tyvaso®) in the Treatment of Pulmonary Hypertension (PH) Associated with Chronic Obstructive Pulmonary Disease (COPD)
Key facts
- Study ID
- NCT01758744
- Run by
- University of Colorado, Denver
- People needed
- 10
- Starts
- 2012-12-01
- Expected to finish
- 2016-07-01
- Last updated by the study team
- 2016-07-20
Who can join
Age: 30 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Colorado Denver — Aurora, Colorado, United States
- University of Florida College of Medicine — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.